Seattle Genetics appoints new Chief Commercial Officer
Seattle Genetics has announced the appointment ofRobin G. Taylor, M.B.A., Ph.D., as Chief Commercial Officer
Pharmaceuticals, Biotechnology and Life Sciences
Seattle Genetics has announced the appointment ofRobin G. Taylor, M.B.A., Ph.D., as Chief Commercial Officer
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/NGS?src=hash" target="_blank"gt;#NGSlt;/agt;–Oncologica, a leading precision oncology profiling company and Contract Research Organization (CRO), has chosen Arkivum to provide…
DUBLIN–(BUSINESS WIRE)–The “Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering.…
Xcenda,a part of AmerisourceBergen, today announced the acquisition ofDymaxium, a trusted market access partner specializing in the exchangeof evidence and information between payers and life science companiesthrough its FormularyDecisions.com® platform.
Debiopharm has enrolled first patient in SMARTPLUS-106, a Phase lb/II study in patients failing prior PD-1/PD-L1 treatment in selected solid tumors.
The development of the UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC) has moved a step closer with the contract to design an advanced array of laboratory and production facilities within a ‘cleanroom wrap’ environment being awarded to WHP, the company has said in a statement.
Japanese government organization to train reviewers to efficiently analyze PBPK model submissions LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), the…
Firm Announces Dr. Midthun as Principal, Drug and Biological Products WASHINGTON–(BUSINESS WIRE)–Greenleaf Health, Inc. (Greenleaf), a leading Food and Drug…
AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced it will be presenting…
Leading biopharmaceutical organizations join Project Baseline initiative to engage more patients and clinicians in research and speed evidence generation SAN…